Drug Discovery · Biotechnology
Relay Therapeutics: Risk & public record
Relay Therapeutics: 103 research papers in five years.
Data updated Nov 22, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
Relay Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
Relay Therapeutics: 103 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
103papers in five years
8.4kcitations
Computational Drug Discovery Methods
Pharmacology, Toxicology and Pharmaceutics
82 papers
Machine Learning in Materials Science
Materials Science
40 papers
Chemical Synthesis and Analysis
Chemistry
20 papers
Protein Structure and Dynamics
Biochemistry, Genetics and Molecular Biology
19 papers
Fibroblast Growth Factor Research
Biochemistry, Genetics and Molecular Biology
16 papers
Works most with: Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Mass General Brigham, The University of Texas MD Anderson Cancer Center, AstraZeneca (United Kingdom), Harvard University
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
